144 ·Filed Sep 10, 2026

PGNY

Progyny, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed22d ago SEC0001959173-26-006853
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine director-level Form 144 filing for a modest share amount relative to market cap. The sale is tied to an option exercise, not a distress signal. Monitor for the actual Form 4 filing to confirm execution, but no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
PGNY ▼ -0.26% at T+5d
NEUTRAL call ✗ call lost -0.26% · α vs SPY +0.24% · entry $27.08 → $27.01
Next anchor: T+20d in 6d
Latest observation: T+15 -8.85% FF3 residual α
Entry anchored
Sep 10, 01:58 PM ET
via 1-min bar
T+1d
+1.00%
call +1.00% · α +0.14%
$27.35
settled 21d ago
T+5d
-0.26%
call -0.26% · α +0.24%
$27.01
settled 15d ago
T+20d
—
call — · α —
—
in 6d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Director Kevin K. Gordon filed a Form 144 notice of intent to sell 11,500 shares of Progyny, Inc. (PGNY) with an approximate market value of $311,859. The sale is planned for execution on or after September 10, 2026, and is associated with a stock option exercise. As a director, this is a routine insider sale and does not carry the same weight as a C-suite disposition. The filing is an advance notice of intent, not a completed sale, and the shares may not ultimately be sold.

Key Facts

  • Director Kevin K. Gordon filed a Form 144 to sell 11,500 shares of PGNY.
  • The approximate market value of the proposed sale is $311,859.
  • The sale is associated with a stock option exercise.
  • The filing date is September 10, 2026, with the sale planned for the same day.
  • The shares are to be sold through Fidelity Brokerage Services LLC.

Financial Impact

Proposed sale of 11,500 shares valued at approximately $311,859, representing a small fraction of the company's $2.1B market cap.

dilution

Risk Factors

  • Insider sale could signal reduced conviction if followed by additional filings from other insiders.
  • The sale is not yet executed; the insider may choose not to sell.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Misc Health & Allied Services, NEC
Analyst Consensus
82% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-006853
Document: 0001959173-26-006853-index.html0001959173-26-006853
Document: 0001959173-26-006853.txt0001959173-26-006853
12 reports for PGNY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PGNY — sortable, filterable
TypeNow
Sep 10, 2026
22d ago
144
NEUTRAL ★ 2/10
$27.08 $27.01▼ −0.26%▲ +0.24%$25.23 (−6.83%)
Jul 23, 2026
10w ago
Press Release
NEUTRAL ★ 2/10
$30.70 $31.49▲ +2.57%▲ +2.10%$25.23 (−17.82%)
Jun 12, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$26.63 $26.08▲ +2.07%▲ +2.74%$25.23 (+5.26%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.48 $25.65▲ +0.67%▲ +3.22%$25.23 (−0.98%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$25.48 $25.65▲ +0.67%▲ +3.22%$25.23 (−0.98%)
May 28, 2026
18w ago
Press Release
BEARISH ★ 6/10
$25.69 $24.99▲ +2.72%▲ +2.68%$25.23 (+1.79%)
May 27, 2026
18w ago
144
NEUTRAL ★ 2/10
$25.48 $25.12▼ −1.41%▼ −2.62%$25.23 (−0.98%)
May 26, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$25.05 $26.20▲ +4.59%▲ +3.51%$25.23 (+0.72%)
May 21, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$24.88 $26.20▲ +5.31%▲ +3.63%$25.23 (+1.41%)
May 21, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.88 $26.20▲ +5.31%▲ +3.65%$25.23 (+1.41%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access